A biotech company that ferments microflora engineered with milk's genes to produce animal-free whey and casein, the dairy proteins used in foods like ice cream, butter and cheese.

Perfect Day bet a network of local, independent producers and processors, not centralized production, would flex supply with demand and dodge COVID-era fragility.

$300M total Series C (extended from an initial $140M close in December 2019)

Perfect Day makes dairy proteins whey and casein without animals, by taking milk's essential genes, adding them to microflora, and using fermentation to convert plant sugar into the same proteins found in cow's milk — proteins already used in products like Smitten N'Ice Cream.

Having closed a $140M Series C in December 2019 led by Temasek, Perfect Day extended the round to $300M in a close led by the Canada Pension Plan Investment Board. CEO Ryan Pandya tied the raise directly to the pandemic's exposure of food-system fragility, saying the company was 'committed to building real change that prioritizes diversity, agility, and resilience.' The company said it planned to start a network of local animal-free dairy protein producers and processors specifically so it could increase or decrease production to match demand, avoiding the supply issues that come from depending on animal-based inputs and centralized facilities — joining a wave of animal-free food startups including Beyond Meat and Impossible Foods.

A single centralized production facility can't flex output quickly, and the pandemic showed the cost of that inflexibility across the food industry.

A network of independently owned local producers spreads capital risk and lets Perfect Day scale output regionally without financing every new plant itself.

Framing the raise around pandemic-era food-system resilience gave a values-aligned investor like a pension fund a clear thesis beyond taste or margin.

A supply-chain shock can justify raising capital to decentralize production infrastructure even for a company whose core technology bet was already proven — resilience becomes its own selling point.

As of 2020-07-08, Perfect Day held $300M in total Series C funding and said it did not plan to slow growth, with the newly announced distributed producer-and-processor network positioned as the mechanism for scaling supply to match demand going forward.

FOLLOW THE EVIDENCE

The sources

  1. Perfect Day Extends Series C Round to $300M news.crunchbase.com